世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Diseases Diagnostic Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5003 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、呼吸器疾患診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（画像検査、呼吸測定、血液ガス検査、その他）、用途別市場規模（病院、医師クリニック、臨床検査室、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・呼吸器疾患診断検査の市場動向 ・企業の競争状況、市場シェア ・呼吸器疾患診断検査の種類別市場規模（画像検査、呼吸測定、血液ガス検査、その他） ・呼吸器疾患診断検査の用途別市場規模（病院、医師クリニック、臨床検査室、その他） ・呼吸器疾患診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器疾患診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器疾患診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器疾患診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器疾患診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Philips Healthcare、BD、Abbott、Thermo Fisher Scientific、Roche、ResMed、Fischer & Paykel、Medtronic、MGC Diagnostics） ・結論

Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases

Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market
The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Diseases Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Diseases Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Diseases Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Diseases Diagnostic Testing market.

Global Respiratory Diseases Diagnostic Testing Scope and Market Size
Respiratory Diseases Diagnostic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Diseases Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other

Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Respiratory Diseases Diagnostic Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Diseases Diagnostic Testing Market Perspective (2016-2027)
2.2 Respiratory Diseases Diagnostic Testing Growth Trends by Regions
2.2.1 Respiratory Diseases Diagnostic Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Diseases Diagnostic Testing Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Diseases Diagnostic Testing Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Diseases Diagnostic Testing Industry Dynamic
2.3.1 Respiratory Diseases Diagnostic Testing Market Trends
2.3.2 Respiratory Diseases Diagnostic Testing Market Drivers
2.3.3 Respiratory Diseases Diagnostic Testing Market Challenges
2.3.4 Respiratory Diseases Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Diseases Diagnostic Testing Players by Revenue
3.1.1 Global Top Respiratory Diseases Diagnostic Testing Players by Revenue (2016-2021)
3.1.2 Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Diseases Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Diseases Diagnostic Testing Revenue
3.4 Global Respiratory Diseases Diagnostic Testing Market Concentration Ratio
3.4.1 Global Respiratory Diseases Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Diseases Diagnostic Testing Revenue in 2020
3.5 Respiratory Diseases Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Respiratory Diseases Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Respiratory Diseases Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Diseases Diagnostic Testing Breakdown Data by Type
4.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2022-2027)

5 Respiratory Diseases Diagnostic Testing Breakdown Data by Application
5.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Respiratory Diseases Diagnostic Testing Market Size (2016-2027)
6.2 North America Respiratory Diseases Diagnostic Testing Market Size by Type
6.2.1 North America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021)
6.2.2 North America Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027)
6.2.3 North America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2027)
6.3 North America Respiratory Diseases Diagnostic Testing Market Size by Application
6.3.1 North America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021)
6.3.2 North America Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027)
6.3.3 North America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2027)
6.4 North America Respiratory Diseases Diagnostic Testing Market Size by Country
6.4.1 North America Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021)
6.4.2 North America Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Respiratory Diseases Diagnostic Testing Market Size (2016-2027)
7.2 Europe Respiratory Diseases Diagnostic Testing Market Size by Type
7.2.1 Europe Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2027)
7.3 Europe Respiratory Diseases Diagnostic Testing Market Size by Application
7.3.1 Europe Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2027)
7.4 Europe Respiratory Diseases Diagnostic Testing Market Size by Country
7.4.1 Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type
8.2.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application
8.3.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region
8.4.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Diseases Diagnostic Testing Market Size (2016-2027)
9.2 Latin America Respiratory Diseases Diagnostic Testing Market Size by Type
9.2.1 Latin America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2027)
9.3 Latin America Respiratory Diseases Diagnostic Testing Market Size by Application
9.3.1 Latin America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2027)
9.4 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country
9.4.1 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type
10.2.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application
10.3.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country
10.4.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Philips Healthcare
11.1.1 Philips Healthcare Company Details
11.1.2 Philips Healthcare Business Overview
11.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Introduction
11.1.4 Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.1.5 Philips Healthcare Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Respiratory Diseases Diagnostic Testing Introduction
11.2.4 BD Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.2.5 BD Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Diseases Diagnostic Testing Introduction
11.3.4 Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Respiratory Diseases Diagnostic Testing Introduction
11.5.4 Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.5.5 Roche Recent Development
11.6 ResMed
11.6.1 ResMed Company Details
11.6.2 ResMed Business Overview
11.6.3 ResMed Respiratory Diseases Diagnostic Testing Introduction
11.6.4 ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.6.5 ResMed Recent Development
11.7 Fischer & Paykel
11.7.1 Fischer & Paykel Company Details
11.7.2 Fischer & Paykel Business Overview
11.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Introduction
11.7.4 Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.7.5 Fischer & Paykel Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Details
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Respiratory Diseases Diagnostic Testing Introduction
11.8.4 Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.8.5 Medtronic Recent Development
11.9 MGC Diagnostics
11.9.1 MGC Diagnostics Company Details
11.9.2 MGC Diagnostics Business Overview
11.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Introduction
11.9.4 MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021)
11.9.5 MGC Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Imaging Test
Table 3. Key Players of Respiratory Measurement
Table 4. Key Players of Blood Gas Test
Table 5. Key Players of Other
Table 6. Global Respiratory Diseases Diagnostic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Diseases Diagnostic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Respiratory Diseases Diagnostic Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Respiratory Diseases Diagnostic Testing Market Share by Regions (2016-2021)
Table 10. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Respiratory Diseases Diagnostic Testing Market Share by Regions (2022-2027)
Table 12. Respiratory Diseases Diagnostic Testing Market Trends
Table 13. Respiratory Diseases Diagnostic Testing Market Drivers
Table 14. Respiratory Diseases Diagnostic Testing Market Challenges
Table 15. Respiratory Diseases Diagnostic Testing Market Restraints
Table 16. Global Respiratory Diseases Diagnostic Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Respiratory Diseases Diagnostic Testing Market Share by Players (2016-2021)
Table 18. Global Top Respiratory Diseases Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2020)
Table 19. Ranking of Global Top Respiratory Diseases Diagnostic Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Respiratory Diseases Diagnostic Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Diseases Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Respiratory Diseases Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Respiratory Diseases Diagnostic Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Philips Healthcare Company Details
Table 64. Philips Healthcare Business Overview
Table 65. Philips Healthcare Respiratory Diseases Diagnostic Testing Product
Table 66. Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 67. Philips Healthcare Recent Development
Table 68. BD Company Details
Table 69. BD Business Overview
Table 70. BD Respiratory Diseases Diagnostic Testing Product
Table 71. BD Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 72. BD Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Respiratory Diseases Diagnostic Testing Product
Table 76. Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Product
Table 81. Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Respiratory Diseases Diagnostic Testing Product
Table 86. Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. ResMed Company Details
Table 89. ResMed Business Overview
Table 90. ResMed Respiratory Diseases Diagnostic Testing Product
Table 91. ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 92. ResMed Recent Development
Table 93. Fischer & Paykel Company Details
Table 94. Fischer & Paykel Business Overview
Table 95. Fischer & Paykel Respiratory Diseases Diagnostic Testing Product
Table 96. Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 97. Fischer & Paykel Recent Development
Table 98. Medtronic Company Details
Table 99. Medtronic Business Overview
Table 100. Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 101. Medtronic Recent Development
Table 102. MGC Diagnostics Company Details
Table 103. MGC Diagnostics Business Overview
Table 104. MGC Diagnostics Respiratory Diseases Diagnostic Testing Product
Table 105. MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2016-2021) & (US$ Million)
Table 106. MGC Diagnostics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Diseases Diagnostic Testing Market Share by Type: 2020 VS 2027
Figure 2. Imaging Test Features
Figure 3. Respiratory Measurement Features
Figure 4. Blood Gas Test Features
Figure 5. Other Features
Figure 6. Global Respiratory Diseases Diagnostic Testing Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Physician Clinics Case Studies
Figure 9. Clinical Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Respiratory Diseases Diagnostic Testing Report Years Considered
Figure 12. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Respiratory Diseases Diagnostic Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Respiratory Diseases Diagnostic Testing Market Share by Regions (2022-2027)
Figure 16. Global Respiratory Diseases Diagnostic Testing Market Share by Players in 2020
Figure 17. Global Top Respiratory Diseases Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Respiratory Diseases Diagnostic Testing Revenue in 2020
Figure 19. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Respiratory Diseases Diagnostic Testing Market Share by Type (2016-2027)
Figure 23. North America Respiratory Diseases Diagnostic Testing Market Share by Application (2016-2027)
Figure 24. North America Respiratory Diseases Diagnostic Testing Market Share by Country (2016-2027)
Figure 25. United States Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Respiratory Diseases Diagnostic Testing Market Share by Type (2016-2027)
Figure 29. Europe Respiratory Diseases Diagnostic Testing Market Share by Application (2016-2027)
Figure 30. Europe Respiratory Diseases Diagnostic Testing Market Share by Country (2016-2027)
Figure 31. Germany Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Region (2016-2027)
Figure 41. China Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Respiratory Diseases Diagnostic Testing Market Share by Type (2016-2027)
Figure 49. Latin America Respiratory Diseases Diagnostic Testing Market Share by Application (2016-2027)
Figure 50. Latin America Respiratory Diseases Diagnostic Testing Market Share by Country (2016-2027)
Figure 51. Mexico Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Share by Country (2016-2027)
Figure 57. Turkey Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Philips Healthcare Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 61. BD Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 65. ResMed Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 66. Fischer & Paykel Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 67. Medtronic Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 68. MGC Diagnostics Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---